Takeda reports positive Phase 2/3 results for investigational immunodeficiency therapy
Galderma to acquire ZO Skin Health for USD1.5bn to expand skincare portfolio
Orexo reports encouraging initial bioavailability results for oral semaglutide formulation
Pharming reports positive Phase II results for leniolisib in genetic immune disorders
Telix to present 20 abstracts on cancer theranostics at EANM Congress
CelLBxHealth secures USD65,000 pharmaceutical research contract
FDA grants Breakthrough Therapy Designation to Legacy Healthcare's CINAINU (LH-8)
Racura Oncology receives approval for RC220 trial to proceed to higher dose
Blue Lake Biotechnology reports interim data from Phase 1/2a paediatric clinical trial of BLB201
Enodia Therapeutics partners with Pfizer on Sec61-targeting drug development
TWINBIRD launches portable freezer targeting dry-ice-free research cold chains
Solvonis signs Portugal agreement to assess European expansion of Phase 3 alcohol addiction trial
Bristol Myers Squibb reports positive Phase 3 results for RYZ101 in neuroendocrine tumours